S. 3140Senate111th Congress (2009-2011)In Committee

Biosecurity and Vaccine Development Improvement Act of 2010

Introduced March 18, 2010

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

March 18, 2010

View full timeline
SenateIntro Referral

Introduced in Senate

March 18, 2010

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S1751-1752)

March 18, 2010

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

March 18, 2010

Floor Debate

7 members

What members said about S. 3140 on the floor

2 Republicans5 Democrats
Edward R. Royce
Rep. Edward R. RoyceR-CA-40 · Jun 30, 2010

Mr. Speaker, this program, Radio Free Asia, was due to expire, under existing law, in September. And I am delighted here, for several reasons, that the legislation is before us. One is because, on a…

Barbara Boxer
Sen. Barbara BoxerD-CA · Mar 18, 2010

Mr. President, as we prepare to reauthorize the Child Nutrition Act, it is critical that we address the need to invest in commonsense ways to improve the health and well being of our nation's most…

Jeff Bingaman
Sen. Jeff BingamanD-NM · Mar 18, 2010

Mr. President, among the many casualties of our economic downturn is the collapse of the primary form of private financing to construct affordable housing. I rise today to introduce the Low-Income…

Arlen Specter
Sen. Arlen SpecterD-PA · Mar 18, 2010

Mr. President, I have sought recognition today to introduce the Biosecurity and Vaccine Development Improvement Act, which will ensure our country has the resources necessary to protect the American…

Arlen Specter
Sen. Arlen SpecterD-PA · Mar 18, 2010

Mr. President, I have sought recognition today to introduce the Biosecurity and Vaccine Development Improvement Act, which will ensure our country has the resources necessary to protect the American…

Show 3 more
Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Jun 30, 2010

Mr. Speaker, I rise in strong support of S. 3140, a bill to permanently authorize Radio Free Asia, and for other purposes. I thank my colleague Senator Lugar for introducing this important bill that…

Diane E. Watson
Rep. Diane E. WatsonD-CA-33 · Jun 30, 2010

Mr. Speaker, I move to suspend the rules and pass the bill (S. 3104) to permanently authorize Radio Free Asia, and for other purposes. Mr. Speaker, I ask unanimous consent that all Members may have 5…

Ileana Ros-Lehtinen
Rep. Ileana Ros-LehtinenR-FL-18 · Jun 30, 2010

Mr. Speaker, I yield such time as he may consume to the gentleman from California (Mr. Royce), the ranking member on the Foreign Affairs Subcommittee on Terrorism, Nonproliferation and Trade, and the…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued March 18, 2010

II

111th CONGRESS

2d Session

S. 3140

IN THE SENATE OF THE UNITED STATES

March 18, 2010

Mr. Specter (for himself and Mr. Casey) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To grant the Secretary of Health and Human Services authority to design, construct, and operate facilities for the purpose of developing and producing biological products in order to meet critical national needs for such biological products, in response to potential bioterrorist attacks or naturally occurring pathogens.

1.

Short title

This Act may be cited as the Biosecurity and Vaccine Development Improvement Act of 2010.

2.

Development and production of biological products

Subpart 1 of part F of title III of the Public Health Service Act (42 U.S.C. 262 et seq.) is amended by adding at the end the following:

352A.

Development and production of biological products

(a)

In general

The Secretary may design, construct, and operate one or more facilities for the purpose of developing and producing biological products to meet critical national needs for such biological products, in response to potential bioterrorist attacks or to naturally occurring pathogens, for which the Secretary determines that private industry has not devoted adequate development effort, or has not produced adequate stocks of, such needed biological products.

(b)

Competitive award

In carrying out the authority described in subsection (a), the Secretary—

(1)

shall ensure that there is competition and may establish a public-private partnership to design, construct, own, and operate a facility described in subsection (a); and

(2)

may use the authority to enter into other transactions under section 319L to establish such a facility.

.